This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Stocks Poised for Breakouts

Sunesis Pharmaceuticals

One biotechnology and drugs stock that's trading very close to triggering a major breakout trade is Sunesis Pharmaceuticals (SNSS - Get Report), which is focused on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. This stock is off to a hot start in 2012, with shares up a whopping 180% so far. I also featured Sunesis recently in " 5 Biotech Stocks Under $10 Blasting Higher."

This company has a catalyst on the horizon; the phase III single interim analysis for its Valor leukemia treatment will be conducted sometime in September. The company has already enrolled 391 patients of the 450 planned for this safety and data study.

If you take a look at the chart for Sunesis Pharmaceuticals, you'll notice that this stock has been uptrending very strong for the last six months, with shares making mostly higher lows and higher highs, which is bullish technical price action. This stock just found buyers right off its 50-day moving average of $2.98 a share, and it's now quickly moving within range of triggering a major breakout trade. The upside volume for SNSS has also been increasing dramatically as it approaches this potential breakout play.

>>22 Biopharma Stocks With Breakout Potential in 2012

Traders should now look for long-biased traders in SNSS once it manages to break out above some near-term overhead resistance levels at $3.27 to $3.38 a share and then above $3.57 to $3.69 a share with high volume. Look for a sustained move or close above all of those levels with volume that hits near or above its three-month average action of 289,147 shares. If that breakout triggers soon, then SNSS should easily head north of $4 a share and possibly tag $5 a share before that catalyst in September.

One could look to buy SNSS off any weakness to anticipate the breakout and simply use a stop that sits just below its 50-day moving average of $2.98 a share. One could also just buy off strength once SNSS clears $3.27 to $3.38 a share with decent volume and then add above the next tier of resistance levels. I would use a stop at around $3.10 if you buy off strength once SNSS clears $3.27 with volume.

Keep in mind that SNSS is a favorite target of the short-sellers. The current short interest as a percentage of the float for SNSS is very high at 11.6%. If that breakout triggers soon, then look for the shorts to help fuel the run higher as the rush to cover some of their bearish bets.
2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
CPRX $0.65 -2.00%
GMCR $91.67 -0.30%
NFLX $91.54 -1.70%
SNSS $0.52 3.00%
SRPT $18.38 2.60%


Chart of I:DJI
DOW 17,769.98 -121.18 -0.68%
S&P 500 2,064.04 -17.39 -0.84%
NASDAQ 4,773.0850 -44.5090 -0.92%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs